Making Sense of Allergic Rhinitis: A Comprehensive Look at Causes, Co-Morbidities, and Effective Treatment Strategies

Rupal Patel Mansukhani, PharmD, and Lucio Volino, PharmD
Published Online: Tuesday, February 18, 2014
Follow Pharmacy_Times:

This activity is supported by an educational grant from Chattem, Inc.
Making Sense of Allergic Rhinitis: A Comprehensive Look at Causes, Co-Morbidities, and Effective Treatment Strategies

Rupal Patel Mansukhani, PharmD
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey

Lucio Volino, PharmD
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey

The following contributors have no relevant financial relationships with commercial interests to disclose.

Rupal Patel Mansukhani, PharmD
Lucio Volino, PharmD

Pharmacy Times Office of Continuing Professional Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Steve Lin, PharmD, RPh; and Donna Fausak

Pharmacy Times
Editorial Staff
—Bea Riemschneider and Kirk McKay

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial inter-ests to disclose.

Educational Objectives
At the conclusion of this knowledge-based CPE activity, pharmacists should be bet-ter prepared to:
  • Review the incidence and basic pathophysiology of allergic rhinitis (AR).
  • Describe the common symptoms, presentation, and complications of AR.
  • Discuss current management of AR, including allergen avoidance, immunotherapy, and pharmacotherapy, including new and emerging dosage formulations.
  • Apply counseling strategies to help address common patient questions and misconceptions to achieve optimal symptom relief.
Release date: February 12, 2014
Expiration date: February 12, 2016
Target audience: Pharmacists
Type of activity: Knowledge
Estimated time to complete activity: 2 hours
Fee: Free

Click here to view this activity.

Description: Description: Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-004-H01-P. The activity is available for CE credit through February 12, 2016.

Related Articles
There are multiple OTC options for nasal steroid sprays
Infant antibiotic use may be linked with disease later in life.
The FDA today approved a new cough and cold treatment that is also intended for adults with symptoms related to upper respiratory allergies.
Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, details some lesser known facts about some allergic rhinitis treatments.
Latest Issues